CC3 COST-EFFECTIVENESS ANALYSIS OF VORETIGENE NEPARVOVEC VERSUS BEST SUPPORTIVE CARE IN PATIENTS WITH RPE65-MEDIATED INHERITED RETINAL DYSTROPHY: A FRENCH HEALTHCARE SYSTEM PERSPECTIVE
| Autor: | Cariou, C., Baba, J., Gherardi, A., Roze, S., Viriato, D. |
|---|---|
| Zdroj: | In Value in Health November 2019 22 Supplement 3:S405-S405 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect